This is the same patient reported under mdr 1000306051-2023-00192 (abbvie complaint # (b)(4)).On 07/dec/2023, pmqa received notification from legal that the plaintiff profile form was received associated with this event.As per the ppf form, the patient underwent a ¿ventral incisional hernia¿ surgery and was implanted with the initial strattice device on (b)(6) 2011.The patient underwent a "ventral incisional hernia repair¿ on (b)(6) 2013 by dr.(b)(6) at (b)(6) hospital.At that time, patient was implanted with another strattice device.The patient underwent a ¿diagnostic laparoscopy and combined laparoscopic and open repair of an incarcerated recurrent incisional hernia with mesh¿ on (b)(6) 2016.As per the ppf form, the patient claims the implantation and failure of the mesh caused ¿pain, recurrence, seroma, adhesions, bowel/intestinal obstruction or blockage, emotional injuries with and without treatment, inflammation, and intervention surgery¿.The form lists the conditions that were treated were ¿pain, recurrence, seroma, adhesions, bowel/intestinal obstruction or blockage, emotional injuries with and without treatment, inflammation, and intervention surgery¿ with approximate dates of treatment as (b)(6) 2016.The ppf form also indicates the patient was implanted with a non-abbvie device, "covidien/medtronic ¿ parietex composite (pco)¿ during the (b)(6) 2016 procedure and underwent a procedure on (b)(6) 2018 for ¿laparoscopic ligation of enterocutaneous fistula.¿.
|
This legal event is being reported as serious injury due to the reported recurrence with surgical intervention.A review of the device history record for strattice lot s11210 has been initiated.If any new, changed or corrected information is noted, a supplemental report will be submitted.This is a known potential adverse event addressed in the product labeling.A relationship between the strattice and this event could not be conclusively determined.Due to the legal process, if additional information is made available during legal proceedings, a supplemental report will be submitted.
|